Common Misconceptions About the Cuban Cancer Vaccine

Cuban cancer vaccine is a vaccine that prevents cancer.

Vaccines are divided into two: preventive vaccines or therapeutic ones. Cuban cancer vaccine is a vaccine that aims to cure.

Does it show its effect in all patients?

The literal meaning of the vaccine or what is expected from a vaccine. It makes it easier for people to overcome the disease by strengthening their own immune system, creating antibodies against cancer cells. Although there is a perception that the vaccine will be effective in all patients when administered, the vaccine is not effective if the person's tumor cell does not have that antigen, as it will create antibodies against certain antigens on the tumor cells.

Cubans smoke a lot of cigarettes and cigars and lung cancer. Did they develop a vaccine for lung cancer because lung cancer is more common?

In order to develop a vaccine against a tumor type, that tumor must contain many mutations and be rich in neoantigens. The most mutagenic tumors are lung cancers, malignant melanoma, a type of skin cancer, bladder tumors, and breast cancer. Studies on the vaccine are therefore being carried out on these cancers.

Does it need to go to Cuba to make sure that the vaccine is administered correctly?

The vaccine must be transported via a cold chain. It is possible to apply it in Turkey as long as the transportation rules are followed.

How long does it take to understand whether the vaccine is effective?

After 5 weeks of application, information about its effectiveness can be obtained. If it is found to be effective, the treatment is continued; otherwise, the vaccine administration is discontinued.

Can it replace standard treatments?

Standard treatments It is suitable for use alongside or in patients who do not respond to standard treatments and cannot receive further chemotherapy.

Is it true that it is most effective in extending the life of the patient by only 2-3 months?

Our general knowledge from general immunotherapy studies is that the treatment responds very well to a group of patients around 10-15%. Clinical studies on the Cuban vaccine continue. Results of Phase III randomized studies It is important to find biomarkers that determine which patients the vaccine is most effective in.

Read: 0

yodax